Biofrontera Inc. Announces Filing Of Supplemental New Drug Application

Reuters
2025.12.02 13:49
portai
I'm PortAI, I can summarize articles.

Biofrontera Inc :BIOFRONTERA INC. ANNOUNCES FILING OF SUPPLEMENTAL NEW DRUG APPLICATION (SNDA) FOR THE TREATMENT OF SUPERFICIAL BASAL CELL CARCINOMA (SBCC) WITH AMELUZ®-PDTBIOFRONTERA: FILING SEEKS TO EXPAND AMELUZ LABEL TO INCLUDE TREATMENT OF SBCC TREATMENT WITH PDT USING ITS BF-RHODOLED OR RHODOLED XL RED LIGHT LAMPS

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer